Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-sirolimus in advanced malignant PEComa
NCT02494570Phase 2Completed
- Sponsor
- Aadi Bioscience, Inc.
- Start
- Oct 2015
- Primary completion
- Nov 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-sirolimus in malignant perivascular epithelioid cell tumor, sponsored by Aadi Bioscience, Inc.. Started Oct 2015; status: completed.
02
Drugs
nab-sirolimus
03
Conditions
malignant perivascular epithelioid cell tumor
Beyond the preview
Go deeper on NCT02494570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494570.